Información del artículo
El síndrome de Brugada es una enfermedad autosómica dominante esporádica que afecta los canales de sodio de los miocardiocitos. Clínicamente se caracteriza por síncopes recurrentes y/o muerte súbita, que en el electrocardiograma simula un bloqueo de rama derecha, acompañado de elevación peculiar del segmento ST en las derivaciones precordiales derechas (V1, V2 y V3) sin alteración cardiaca estructural. Afecta principalmente a hombres en la cuarta década de la vida y tiene mayor prevalencia en el suroeste asiático. El caso que se describe corresponde a un paciente con antecedentes personales de síncopes, a quien se le encuentra un patrón electrocardiográfico tipo-2 de Brugada y quien además tiene un hermano con historia de síncopes. Con una prueba de mesa basculantes positivo para síncope mediado neuralmente se deja este diagnóstico, pero no se descarta la sospecha inicial de síndrome de Brugada.
Palabras clave:
síndrome de Brugada
síncope
muerte súbita
arritmias
patrones electrocardiográficos tipo Brugada
canales de sodio cardiacos
bloqueadores de canales de sodio
Brugada syndrome is a sporadic autosomal dominant genetic disease that affects cardiac sodium channels. It is clinically characterized by recurrent syncope and/or sudden death with electrocardiographic manifestations that simulate a right bundle branch block accompanied by ST-segment elevation in the right precordial leads (V1, V2 and V3) without structural cardiac changes. It mainly affects men in their fourth decade and is most prevalent in southwestern Asia. We present the case of a patient with history of syncope, type-2 Brugada electrocardiographic pattern and who has a brother also with history of syncope. The patient had a positive tilt test for neurocardiogenic syncope. He was diagnosed as neurocardiogenic syndrome, without discarding the initial suspicion of Brugada syndrome.
Key words:
Brugada syndrome
syncope
sudden death
arrhythmias
Brugada-type electrocardiographic patterns
cardiac sodium channels
sodium channel blockers
El Texto completo está disponible en PDF
Bibliografía
[1.]
P. Brugada, J. Brugada.
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.
J Am Coll Cardiol, 20 (1992), pp. 1391-1396
[2.]
A.R. Pérez Riera, C.F. Filho, A.H. Uchida, et al.
Study of the extent of the information of cardiologists from São Paulo city, Brazil, regarding a low-prevalence entity: Brugada syndrome.
Ann Noninvasive Electrocardiol, 13 (2008), pp. 352-363
[3.]
H. Oe, M. Tagaki, A. Tanaka, et al.
Prevalence and clinical course of the juveniles with Brugada-type ECG in japanese population.
Pacing Clin Electrophysiol, 28 (2005), pp. 549-554
[4.]
K.P. Letsas, G. Gavrielatos, M. Efremidis, et al.
Prevalence of Brugada sign in a Greek tertiary hospital population.
Europace, 9 (2007), pp. 1077-1080
[5.]
M.J. Junttila, M.J. Raatikainen, J. Karjalainen, H. Kauma, Y.A. Kesäniemi, H.V. Huikuri.
Prevalence and prognosis of subjects with Brugada-type ECG pattern in a young and middle-aged Finnish population.
Eur Heart J, 25 (2004), pp. 874-878
[6.]
M.M. Gallagher, G.B. Forleo, E.R. Behr, et al.
Prevalence and significance of Brugadatype ECG in 12,012 apparently healthy European subjects.
Int J Cardiol, 130 (2008), pp. 44-48
[7.]
H. Ito, K. Yano, R. Chen, Q. He, J.D. Curb.
The prevalence and prognosis of a Brugadatype electrocardiogram in a population of middle-aged japanese-american men with follow-up of three decades.
Am J Med Sci, 331 (2006), pp. 25-29
[8.]
Y. Miyasaka, H. Tsuji, K. Yamada, et al.
Prevalence and mortality of the Brugadatype electrocardiogram in one city in japan.
J Am Coll Cardiol, 38 (2001), pp. 771-774
[9.]
H.V. Abrego, R. Suárez, A.E. Sandoval.
Prevalencia de patrones electrocardiográficos tipo Brugada en un centro de monitoreo cardíaco transtelefónico en El Salvador.
Rev Costarr Cardio, 8 (2006), pp. 13-17
[10.]
D. Donohue, F. Tehrani, R. Jamehdor, C. Lam, M.R. Movahed.
The prevalence of Brugada ECG in adult patients in a large university hospital in the western United States.
Am Heart Hop J, 6 (2008), pp. 48-50
[11.]
H. Blangy, N. Sadoul, J.M. Coutelour, et al.
Prevalence of Brugada syndrome among 35,309 inhabitants of Lorraine screened at a preventive medicine centre.
Arch Mal Coeur Vaiss, 98 (2005), pp. 175-180
[12.]
M. Yoshinaga, R. Anan, Y. Nomura, et al.
Prevalence and time of appearance of Brugada electrocardiographic pattern in young male adolescents from a three-year follow-up study.
Am J Cardiol, 94 (2004), pp. 1186-1189
[13.]
R.W. Greer, D.L. Glancy.
Prevalence of the Brugada electrocardiographic pattern at the Medical Center of Louisiana in New Orleans.
State Med Soc, 155 (2003), pp. 242-246
[14.]
G. Gervacio-Domingo, J. Isidro, J. Tirona, et al.
The Brugada type 1 electrocardiographic pattern is common among Filipinos.
J Clin Epidemiol, 61 (2008), pp. 1067-1072
[15.]
J.S. Hermida, J.L. Lemoine, F.B. Aoun, G. Jarry, J.L. Rey, J.C. Quiret.
Prevalence of the Brugada syndrome in an apparently healthy population.
Am J Cardiol, 86 (2000 1), pp. 91-94
[16.]
C. Napolitano, S.G. Priori.
Brugada syndrome.
Orphanet J Rare Dis, 1 (2006), pp. 1-6
[17.]
L. Littmann, M.H. Monroe.
The Brugada numbers.
Circulation, 107 (2003), pp. e122
[18.]
A.A. Wilde, C. Antzelevitch, M. Borggrefe, et al.
Proposed diagnostic criteria for the Brugada syndrome: consensus report.
Circulation, 106 (2002), pp. 2514-2519
[19.]
G. Allocca, A. Proclemer, G. Nucifora, E. Dall’Armellina, L. Rebellato.
Monomorphic ventricular tachycardia in Brugada syndrome: clinical case and literature review.
J Cardiovascu Med (Hagerstown), 9 (2008), pp. 842-846
[20.]
C. Antzelevitch, P. Brugada, M. Borggrefe, et al.
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.
Circulation, 11 (2005), pp. 659-670
[21.]
Q. Chen, G.E. Kirsch, D. Zhang, et al.
Genetic basis and molecular mechanism for idiopathic ventricular fribrillation.
Nature, 392 (1998), pp. 293-296
[22.]
A.L. George Jr..
Inherited disorders of voltage-gated sodium channels.
J Clin Invest, 115 (2005), pp. 1990-1999
[23.]
R. Li, G. Tomaselli, E. Marbin.
Sodium Channels.
Cardiac Electrophysiology, From Cell to beside, Fourth Edition ed, pp. 1-8
[24.]
J. Balser.
Biophysics of cardiac ion chanel function.
Cardiac Electrophysiology, From Cell to beside, Fourth Edition ed, pp. 77-83
[25.]
K. Ohkubo, I. Watanabe, Y. Okumura, S. Ashino, M. Kofune, M. Ohta, et al.
Surface ECG characteristics of ventricular tachyarrhythmias before degenaration into ventricular fibrilation in patients with Brugada-type ECG.
Int heart J, 50 (2009), pp. 477-487
[26.]
B. Benito, J. Brugada, R. Brugada, P. Brugada.
Brugada syndrome.
Rev Esp Cardiol, 62 (2009), pp. 1297-1315
[27.]
H. Itoh, T. Sakaguchi, T. Ashihara, et al.
A novel KCNH2 mutation as a modifier for short QT interval.
Int J Cardiol, 137 (2009), pp. 83-85
[28.]
M.F. Márquez, D. Cruz-Robles, S. Inés-Real, et al.
A novel SCN5A deletion mutation in a child with ventricular tachycardia, recurrent aborted sudden death, and Brugada electrocardiographic pattern.
Arch Cardiol Mex, 77 (2007), pp. 284-287
[29.]
N. Makita, N. Mochizuki, H. Tsutsui.
Absence of a trafficking defect in R1232W/T1620M, a double SCN5A mutant responsible for Brugada syndrome.
Circ J, 72 (2008), pp. 1018-1019
[30.]
J.M. Cordeiro, H. Barajas-Martinez, K. Hong, et al.
Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
Circulation, 114 (2006), pp. 2026-2033
[31.]
G. Vorobiof, D. Kroening, B. Hall, R. Brugada, D. Huang.
Brugada syndrome with marked conduction disease: dual implications of a SCN5A mutation.
Pacing Clin Electrophysiol, 31 (2008), pp. 630-634
[32.]
G. Frigo, A. Rampazzo, B. Bauce, et al.
Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities.
Europace, 9 (2007), pp. 391-397
[33.]
P.J. Mohler, I. Rivolta, C. Napolitano, et al.
Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.
Proc Natl Acad Sci U S A, 101 (2004), pp. 17533-17538
[34.]
N. Makita, N. Sumitomo, I. Watanabe, H. Tsutsui.
Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
Heart Rhythm, 4 (2007), pp. 516-519
[35.]
H. Watanabe, T.T. Koopmann, S. Le Scouarnec, et al.
Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans.
J Clin Invest, 118 (2008), pp. 2260-2268
[36.]
R. Weiss, M.M. Barmada, T. Nguyen, et al.
Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3.
Circulation, 105 (2002), pp. 707-713
[37.]
B. London, M. Michalec, H. Mehdi, et al.
Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias.
Circulation, 116 (2007), pp. 2260-2268
[38.]
C. Antzelevitch, G.D. Pollevick, J.M. Cordeiro, et al.
Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death.
Circulation, 115 (2007), pp. 442-449
[39.]
D. Haruta, K. Matsuo, S. Ichimaru, M. Soda, A. Hida, N. Sera, et al.
Men with Brugadalike electrocardiogram have higher risk of prostate cancer.
Circ J, 73 (2009), pp. 63-68
[40.]
K. Matsuo, M. Akahoshi, S. Seto, K. Yano.
Disappearance of the Brugada-type electrocardiogram after surgical castration: A role for testosterone and an explanation for the male preponderance.
Pacing Clin Electrophysiol, 26 (2003), pp. 1551-1553
[41.]
Y.M. Shuba, V.E. Degtiar, N. Osipenko, V.G. Naidenov, R.L. Woosley.
Testosteronemediated modulation of HERG blockage by proarrhythmic agents.
Biochem Pharmacol, 62 (2001), pp. 41-49
[42.]
X.K. Liu, A. Katchman, B.H. Whitfield, G. Wan, E.M. Janowski, R.L. Woosley.
In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium current in orchiectomized male rabbits.
Cardiovasc Res, 57 (2003), pp. 28-36
[43.]
C.X. Bai, J. Kurosawa, M. Tamagawa, H. Nakaya, T. Fukukawa.
Nontranscriptional regulation of cardiac repolarization currents by testosterone.
Circ J, 112 (2005), pp. 1701-1710
[44.]
W. Shimizu, K. Matsuo, Y. Kokubo, K. Satomi, T. Kurita, T. Noda.
Sex hormone and gender difference-role of testosterone on male predominance in Brugada syndrome.
J Cardiovasc Electrophysiol, 18 (2007), pp. 415-421
[45.]
A. Frustaci, S.G. Priori, M. Pieroni, et al.
Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome.
Circulation, 112 (2005), pp. 3680-3687
[46.]
B. Benito, R. Brugada, J. Brugada, P. Brugada.
Brugada syndrome.
Prog Cardiovasc Dis, 51 (2008), pp. 1-22
[47.]
L. Eckardt, P. Kirchhof, P. Loh, et al.
Brugada syndrome and supraventricular tachyarrhythmias: a novel association?.
J Cardiovasc Electrophysiol, 12 (2001), pp. 680-685
[48.]
M. Alings, A. Wilde.
“Brugada” syndrome: clinical data and suggested pathophysiological mechanism.
Circulation, 99 (1999), pp. 666-673
[49.]
P. Brugada, R. Brugada, C. Antzelevitch, J. Brugada.
The Brugada syndrome.
Arch Mal Coeur Vaiss, 98 (2005), pp. 115-122
[50.]
K. Mizumaki, A. Fujiki, T. Tsuneda, et al.
Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome.
J Cardiovasc Electrophysiol, 15 (2004), pp. 667-673
[51.]
M. Vatta, R. Dumaine, G. Varghese, et al.
Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome.
Hum Mol Genet, 11 (2005), pp. 337-345
[52.]
A. Abud, D. Bagattin, O. Lujan, O. Birollo, J. Lovecchio.
Detección de un síndrome de Brugada en las derivaciones precordiales altas del electrocardiograma de doce derivaciones.
Rev Fed Arg Cardiol, 32 (2003), pp. 107-109
[53.]
M.M. Civetta, S.M. Moro, P.A. Chiale, M.V. Elizari, J.R. Escobar, S.J. Sicouri.
El efecto preferencial de la ajmalina sobre el epicardio ventricular derecho canino puede explicar las manifestaciones electrocardiográficas del síndrome de Brugada.
Rev Fed Arg Cardiol, 70 (2002), pp. 118-125
[54.]
T. Katsuyuki, O. Hidetaka, T. Shinhiro, T. Keiji, S. Atsuhiro.
Unmasking of Brugada syndrome by an antiarrhythmic drug in a patient with septic shock.
J Anesth Analg, 102 (2006), pp. 233-236
[55.]
J. Brugada, R. Brugada, P. Brugada.
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.
Circulation, 108 (2003), pp. 3092-3096
[56.]
J.S. Hermida, I. Denjoy, G. Jarry, S. Jandaud, C. Bertrand, J. Delonca.
Electrocardiographic predictors of Brugada type response during Na channel blockade challenge.
Europace, 7 (2005), pp. 447-453
[57.]
H. Morita, K.F. Kusano, D. Miura, S. Nagase, K. Nakamura, S.T. Morita, et al.
Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome.
Circ J, 118 (2008), pp. 1697-1704
[58.]
A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in colla boration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
J Am Coll Cardiol, 51 (2008), pp. e1-e62
[59.]
B. Belhassen, A. Glick, S. Viskin.
Efficacy of quinidine in high-risk patients with Brugada syndrome.
Circulation, 110 (2004), pp. 1731-1737
[60.]
T. Tsuchiya, K. Ashikaga, T. Honda, M. Arita.
Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome.
J Cardiovasc Electrophysiol, 13 (2002), pp. 698-701
[61.]
A. Abud, D. Bagattin, R. Goyeneche, C. Becker.
Failure of cilostazol in the prevention of ventricular fibrillation in a patient with Brugada syndrome.
J Cardiovasc Electrophysiol, 17 (2006), pp. 210-212
[62.]
B. Benito, J. Brugada.
Recurrent syncope: an unusual presentation of Brugada syndrome.
Nat Clin Pract Cardiovasc Med, 3 (2006), pp. 573-577
[63.]
A.I. Bodegas, J.I. Arana, Y. Vitoria, J.R. Arriandiaga, J.I. Barrenetxea.
Brugada syndrome in a patient with accessory pathway.
Europace, 4 (2002), pp. 87-89
[64.]
K.P. Letsas, M. Efremidis, G. Gavrielatos, G.S. Filippatos, A. Sideris, F. Kardaras.
Neurally mediated susceptibility in individuals with Brugada-Type ECG pattern.
Pacing Clin Electrophysiol, 31 (2008), pp. 418-421
[65.]
M. Nomura, T. Nada, J. Endo, Y. Kondo, M. Yukinaka, K. Saito, et al.
Brugada syndrome associated with an autonomic disorder.
Heart, 80 (1998), pp. 194-196
[66.]
J. Ortega-Carnicer, J. Benezet, P. Calderón-Jiménez, J. Yanes-Martín.
Hypothermiainduced Brugada-like electrocardiogram pattern.
J Electrocardiol, 41 (2008), pp. 690-692
[67.]
F.E. Gallahue, R. Uzgiris, R. Burke, W. Abrahams.
Brugada syndrome presenting as an “acute myocardial infarction”.
J Emerg Med, 37 (2009), pp. 15-20
Copyright © 2010. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular